These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2866300)

  • 21. Treatment of serious Pseudomonas infections with azlocillin.
    Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
    J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobramycin sulfate: a summary of worldwide experience from clinical trials.
    Bendush CL; Weber R
    J Infect Dis; 1976 Aug; 134 Suppl():S219-34. PubMed ID: 787450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract]   [Full Text] [Related]  

  • 24. An outbreak of Pseudomonas aeruginosa in a burn unit.
    Pednekar SN; Dohe VB; Deshpande SM; Kamble SS; Bharadwaj RS; Shouche YS
    Burns; 2010 Nov; 36(7):e130-1. PubMed ID: 20883907
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa in dermatology].
    Morand A; Morand JJ
    Ann Dermatol Venereol; 2017 Nov; 144(11):666-675. PubMed ID: 28778416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New perspectives in the management of Pseudomonas aeruginosa infections.
    Savoia D
    Future Microbiol; 2014; 9(7):917-28. PubMed ID: 25156380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa in hospital sinks.
    Ayliffe GA; Babb JR; Collins BJ; Lowbury EJ; Newsom SW
    Lancet; 1974 Sep; 2(7880):578-81. PubMed ID: 4140284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug resistance in Pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in Aleppo, Syria.
    Mahfoud M; Al Najjar M; Hamzeh AR
    J Infect Dev Ctries; 2015 Feb; 9(2):210-3. PubMed ID: 25699497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of Pseudomonas aeruginosa septicemia in burns].
    Wang DW
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Sep; 3(3):181-3, 237-8. PubMed ID: 3151607
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudomonas infections of skin: an experimental study.
    Singh G
    Int J Dermatol; 1974; 13(2):90-3. PubMed ID: 4363237
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract]   [Full Text] [Related]  

  • 32. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic respiratory infections.
    Popescu C; Meitert E; Rusu R; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):265-76. PubMed ID: 6818929
    [No Abstract]   [Full Text] [Related]  

  • 34. Microbiology for orthopaedic surgeons: selected aspects.
    Monson TP; Nelson CL
    Clin Orthop Relat Res; 1984 Nov; (190):14-22. PubMed ID: 6149028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.
    Oh SH; Park HS; Kim HS; Yun JY; Oh K; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2017 Dec; 50(6):700-706. PubMed ID: 28668680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiences in the treatment of skin infections due to Pseudomonas aeruginosa with Kasugamycin vaseline].
    Kanaue F; Oura T; Tanifuji J
    J Antibiot B; 1967 Jun; 20(3):187-90. PubMed ID: 4965583
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of Pseudomonas aeruginosa in infections.
    Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():1-13. PubMed ID: 6413479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of immunotherapy for infections due to Pseudomonas aeruginosa.
    Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S149-51. PubMed ID: 4138585
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.